Quantcast
Tag archive for ‘drugs and supplements’
By The Dispatch On Thursday, July 3rd, 2014
0 Comments

Spectrum Pharmaceuticals Beleodaq for non-Hodgkin lymphoma treatment gets FDA nod

The U.S. Food and Drug Administration today approved Beleodaq (belinostat) for the treatment of patients with peripheral T-cell lymphoma (PTCL), a rare and fast-growing type of non-Hodgkin lymphoma (NHL). The action More...

By The Dispatch On Friday, June 20th, 2014
0 Comments

Phase I study for MRSA, VISA drug, Debio 1450 launched

Debiopharm Group™ (Debiopharm), a Swiss-based global biopharmaceutical company developing prescription drugs that target unmet medical needs as well as companion diagnostics, today announced the launch of a Phase More...

By The Dispatch On Wednesday, June 18th, 2014
1 Comment

Janssen Announces License Agreement With Vertex for development of VX-787, a novel influenza A drug

PRESS RELEASE TITUSVILLE, NJ, July 18, 2014 – Janssen Pharmaceuticals, Inc. (Janssen) announced today that it has entered into an exclusive license agreement with Vertex Pharmaceuticals for the worldwide development, More...

By The Dispatch On Friday, June 6th, 2014
0 Comments

Eloctate, Antihemophilic Factor receives FDA approval for treatment of Hemophilia A

The U.S. Food and Drug Administration today approved Eloctate, Antihemophilic Factor (Recombinant), Fc fusion protein, for use in adults and children who have Hemophilia A. Eloctate is the first Hemophilia A treatment More...

By The Dispatch On Friday, May 30th, 2014
0 Comments

Celebrex generics receive FDA approval for RA treatment

PRESS RELEASE The U.S. Food and Drug Administration today approved the first generic versions of Celebrex (celecoxib) capsules, a treatment for rheumatoid arthritis, osteoarthritis, short-term (acute) pain, and More...

By The Dispatch On Friday, May 23rd, 2014
2 Comments

Dalvance receives FDA approval for the treatment of Staph and Strep skin infections

PRESS RELEASE The U.S. Food and Drug Administration today approved Dalvance (dalbavancin), a new antibacterial drug used to treat adults with skin infections. MRSAImage/CDC Dalvance is intended to treat acute bacterial More...

By The Dispatch On Wednesday, May 21st, 2014
2 Comments

Entyvio receives FDA approval for the treatment of ulcerative colitis and Crohn’s disease

The U.S. Food and Drug Administration Tuesday approved Entyvio (vedolizumab) injection to treat adult patients with moderate to severe ulcerative colitis and adult patients with moderate to severe Crohn’s disease.Entyvio More...

By Robert On Thursday, May 15th, 2014
0 Comments

Sleep drug, Lunesta, to be relabeled with lower starting dose: FDA

PRESS RELEASE The U.S. Food and Drug Administration today announced it required the manufacturer of the sleep drug Lunesta (eszopiclone) to change the drug label and lower the current recommended starting dose. More...

By The Dispatch On Thursday, May 8th, 2014
0 Comments

Zontivity tablets, to reduce heart attacks and strokes, gets FDA approval

PRESS RELEASE   The U.S. Food and Drug Administration today approved Zontivity (vorapaxar) tablets to reduce the risk of heart attack, stroke, cardiovascular death, and need for procedures to restore the blood More...

By The Dispatch On Tuesday, April 29th, 2014
0 Comments

Lung cancer drug, Zykadia, receives accelerated FDA approval

PRESS RELEASE The U.S. Food and Drug Administration today granted accelerated approval to Zykadia (ceritinib) for patients with a certain type of late-stage (metastatic) non-small cell lung cancer (NSCLC). Zykadia More...

By The Dispatch On Wednesday, April 23rd, 2014
0 Comments

Castleman’s disease drug, Sylvant, gets FDA approval

The U.S. Food and Drug Administration today approved Sylvant (siltuximab) to treat patients with multicentric Castleman’s disease (MCD), a rare disorder similar to lymphoma (cancer of the lymph nodes). MCD causes More...

By The Dispatch On Monday, April 21st, 2014
0 Comments

Stomach cancer drug, Cyramza, receives FDA approval

PRESS RELEASE The U.S. Food and Drug Administration today approved Cyramza (ramucirumab) to treat patients with advanced stomach cancer or gastroesophageal junction adenocarcinoma, a form of cancer located in the More...

By The Dispatch On Thursday, April 17th, 2014
0 Comments

Hay fever drug, Ragwitek, receives FDA approval

PRESS RELEASE The U.S. Food and Drug Administration today approved Ragwitek, the first allergen extract administered under the tongue (sublingually) to treat short ragweed pollen induced allergic rhinitis (hay fever), More...

By The Dispatch On Wednesday, April 16th, 2014
1 Comment

Oral antiviral drug developed for combating measles shows encouraging early results

PRESS RELEASE A novel antiviral drug may protect people infected with the measles from getting sick and prevent them from spreading the virus to others, an international team of researchers says. Scientists from More...

By The Dispatch On Wednesday, April 16th, 2014
2 Comments

Diabetes drug, Tanzeum, receives FDA approval

PRESS RELEASE The U.S. Food and Drug Administration Tuesday approved Tanzeum (albiglutide) subcutaneous injection to improve glycemic control, along with diet and exercise, in adults with type 2 diabetes. Type More...

By The Dispatch On Thursday, April 3rd, 2014
0 Comments

Evzio, for reversing opioid overdose, gets FDA approval

PRESS RELEASE The U.S. Food and Drug Administration today approved a prescription treatment that can be used by family members or caregivers to treat a person known or suspected to have had an opioid overdose. Evzio More...

By The Dispatch On Monday, March 31st, 2014
2 Comments

Sivextro, to treat MRSA skin infections, receives recommendation from FDA Anti-Infective Drugs Advisory Committee

PRESS RELEASE Cubist Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) Anti-Infective Drugs Advisory Committee (AIDAC) voted to recommend approval of Cubist’s investigational More...

By Robert On Friday, March 28th, 2014
0 Comments

Janssen Pharmaceuticals, Topamax, for migraine prevention gets FDA nod

PRESS RELEASE Today, the U.S. Food and Drug Administration approved Topamax (topiramate) for prevention (prophylaxis) of migraine headaches in adolescents ages 12 to 17. This is the first FDA approval of a drug More...

By The Dispatch On Friday, March 21st, 2014
1 Comment

Celgene’s Otezla receive FDA approval for treating psoriatic arthritis

PRESS RELEASE The U.S. Food and Drug Administration today approved Otezla (apremilast) to treat adults with active psoriatic arthritis (PsA). PsA is a form of arthritis that affects some people with psoriasis. Most More...

By The Dispatch On Wednesday, March 19th, 2014
1 Comment

Impavido to treat leishmaniasis receives FDA approval

PRESS RELEASE The U.S. Food and Drug Administration today approved Impavido (miltefosine) to treat a tropical disease called leishmaniasis. Phlebotomus papatasi sand flyImage/CDC Leishmaniasis is a disease caused More...


Recent Posts


DISPATCH BLOGS

Splash Page logo 300x146 Today in History